Guess which ASX 200 healthcare share just rocketed 11% on 'groundbreaking trial' fool.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fool.com.au Daily Mail and Mail on Sunday newspapers.
Market wrap: ASX lists in broad rebound on Monday trading | news.com.au — Australia's leading news site news.com.au - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news.com.au Daily Mail and Mail on Sunday newspapers.
Neuren Phase 2 trial shows significant improvements in Pitt Hopkins syndrome | Taiwan News taiwannews.com.tw - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from taiwannews.com.tw Daily Mail and Mail on Sunday newspapers.
Neuren Phase 2 trial shows significant improvements in Pitt Hopkins syndrome fnarena.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from fnarena.com Daily Mail and Mail on Sunday newspapers.
Neuren Pharmaceuticals announced top-line results from its Phase 2 clinical trial of NNZ-2591 in children with Pitt Hopkins syndrome . Statistically significant improvement from baseline was observed.